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Abstract
Background: In vitro isolated heart preparations are valuable tools for the study of cardiac anatomy and
physiology, as well as for preclinical device testing. Such preparations afford investigators a high level of
hemodynamic control, independent of host or systemic interactions. Here we hypothesize that recovered human
and swine heart-lung blocs can be reanimated using a clear perfusate and elicit viable cardiodynamic and
pulmonic function. Further, this approach will facilitate multimodal imaging, which is particularly valuable for the
study of both functional anatomy and device-tissue interactions. Five human and 18 swine heart-lung preparations
were procured using techniques analogous to those for cardiac transplant. Specimens were then rewarmed and
reperfused using modifications of a closed circuit, isolated, beating and ventilated heart-lung preparation. Positive
pressure mechanical ventilation was also employed, and epicardial defibrillation was applied to elicit native cardiac
sinus rhythm. Videoscopy, fluoroscopy, ultrasound, and infrared imaging were performed for anatomical and
experimental study.
Results: Systolic and diastolic left ventricular pressures observed for human and swine specimens were 68/2 ± 11/7
and 74/3 ± 17/5 mmHg, respectively, with associated native heart rates of 80 ± 7 and 96 ± 16 beats per minute.
High-resolution imaging within functioning human pulmonary vasculature was obtained among other anatomies of
interest. Note that one human specimen elicited poor cardiac performance post defibrillation.
Conclusions: We report the first dynamic videoscopic images of the pulmonary vasculature during viable
cardiopulmonary function in isolated reanimated heart-lung blocs. This experimental approach provides unique in
vitro opportunities for the study of novel medical therapeutics applied to large mammalian, including human,
heart-lung specimens.
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Background
In vitro isolated heart preparations have been a corner-
stone of cardiac research since Langendorff ’s original
methodology was described in the 1890s [1]. The bene-
fits of isolated heart research are numerous and can be
remarkable depending on the investigator’s goal. Isolated
heart preparations offer a high degree of control over
the system including, but not limited to: perfusate selec-
tion, flow control, and pre- and after-load variability. For
a thorough historic summary of these experimental
models the reader is referred to a review by Hill et al.
[2]. Furthermore, applied pharmacological studies using
such approaches can help elucidate the direct action of
agents on isolated cardiac tissues, i.e., while avoiding
systemic interactions of other agents or breakdown
products (e.g., cardiac-nervous system, hepatic metabol-
ism, etc.) [3].
More recently, high-throughput cardiac perfusion sys-
tems are being designed, or now even purchased off the
shelf, in which multiple small mammalian hearts can be
experimented on simultaneously. Isolated heart prepara-
tions have garnered notable insights to mechanisms of
arrhythmias [4] and have been reviewed elsewhere [5].
Depending upon the system configuration, a wide range
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of equipment and modalities are available to the investiga-
tor including: electrophysiologic monitoring and pacing,
ultrasonography, ultrasonic stimulation, fluoroscopy, in-
frared thermography, direct visualization via videoscopes,
and anatomical mapping systems. Furthermore, the
utilization of large mammalian isolated hearts allows for
critical preclinical testing of device-tissue interactions in
native human anatomies or in large mammalian anat-
omies highly similar to humans, i.e., if the proper animal
model is selected for investigation [6]. Comparative im-
aging of normal versus pathologic conditions, or interspe-
cies comparisons to determine optimal approaches,
models, and designs has been critical for the development
of novel therapeutics [7]. To the medical device designer,
engineer, or clinician, these insights have proven to be es-
sential for enhancing productivity and are of high educa-
tional value [8, 9].
Despite isolated heart preparations being a valuable
tool, proper anatomical relationships can be compro-
mised when the lungs are removed. This is particularly
true when the pulmonary veins and their native ostia are
of interest in the context of therapeutic applications,
e.g., for treating atrial fibrillation by the isolation of the
pulmonary veins via ablation. More specifically, heart-
lung preparations have been utilized previously to eluci-
date the release of atrial natriuretic peptide [10] and ex-
pand the pool of lung transplants to non-beating donors
[11]; they have also been used in numerous pharmaco-
logic studies. Interestingly, the first heart-lung prepara-
tions are often attributed to Knowlton and Starling [12],
however their work acknowledges the methods of
Martin [13] which were presented in lecture at Johns
Hopkins in 1883. The first publication by Martin of his
heart-lung bloc preparation was released in 1881 [14],
therefore predating Langendorff ’s work by 14 years. In
short, this preparation cannulates in situ the superior
vena cava and one of the branches coming off the aortic
arch. A closed loop is created by which pressure can be
monitored, a compliance chamber is incorporated, and
pre- and after-loads are varied.
Our laboratory previously reported on the reanimation
of human hearts, those non-viable for transplant, using an
isolated experimental apparatus [2] and Visible Heart®
methodologies [15]. Here we describe expanding these ex-
perimental approaches to incorporate intact large mam-
mal heart-lung blocs, including both human and swine
specimens. To the authors’ knowledge, this is the first de-
scription of large mammalian heart-lung blocks being
used to achieve dynamic videoscopic imaging in the pul-
monary vasculature. We hypothesized that recovered hu-
man and swine heart-lung blocs could be reanimated
using a clear perfusate and elicit viable hemodynamic and
pulmonic function for numerous hours. Further, this ap-
proach would facilitate multimodal imaging, which is
particularly valuable for the study of functional anatomy
and device-tissue interactions.
Methods
Human and swine isolated heart-lung blocs were reani-
mated with either the right, left, or both lungs attached,
employing Visible Heart® methodologies [15]. The detailed
procurement procedure has been described previously [2,
15]. Briefly, a median sternotomy was performed and an
aortic root cannula implanted for delivery of cardioplegia.
The inferior vena cava (IVC) was ligated and, just prior to
cardioplegia delivery, the IVC for human preparations was
typically removed with the liver if it was being recovered
for transplant, and the superior vena cava (SVC) and aorta
were cross-clamped. Cardioplegia was then delivered
under pressure to rapidly cool and arrest the heart. The
heart and lungs were then dissected and the heart-lung
bloc removed by transection of the major vessels, trachea,
and esophagus. The human specimens were then trans-
ported on ice to the laboratory within 4–8 h following
cross-clamp depending upon the logistics of transporta-
tion. The human heart-lung specimens were considered
as non-viable for transplantation, i.e., due to unknown car-
diac arrest periods, significant cardiac disease, and/or
other complications. An analogous procedure was per-
formed on swine hearts in our laboratory (mean animal
weight of 84 ± 14 kg; n = 18) using two liters of 4 °C St.
Thomas’ cardioplegia for induction of cardiac arrest. We
have typically performed these studies with just one lung
attached, but the method has been adapted to include
both lungs. Preparations with only one lung allow cannu-
lation of the non-utilized pulmonary vein, which may be
used to more easily access the left atrium for imaging and/
or device placement.
Upon arrival of the human specimens (or after ex-
plantation of those from swine), heart-lung blocs were
placed in an ice slurry of modified Krebs-Henseleit buf-
fer while cannulation of the great vessels was performed
(i.e., IVC, SVC, and aorta). If a one-lung preparation was
desired, the left/right pulmonary veins and artery were
dissected from the left/right lung, and the lung was re-
moved. These vessels were cannulated as well, and
hemostasis valves were fitted for access. If both lungs
were desired in the preparation, the pulmonary trunk
was cannulated to allow control of the buffer flow, either
directing all flow through the lungs or allowing some
flow to the reservoir (i.e., a parallel path through the lungs
and to the reservoir). An intubation tube was placed in
the trachea and connected to a ventilator to control flow
through the remaining airways. Preparations were typic-
ally ventilated at a respiration rate of 11–15 per minute
and at volumes of 150–250 ml per lung.
The heart-lung blocs were then connected to the ap-
paratus described in detail previously [15]. A schematic
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of this system, adapted for heart-lung blocs, can be
found in Fig. 1. The system was altered to vary the afore-
mentioned parameters of other isolated heart research
systems, and functioned in either partial or four-
chamber working mode. Partial working mode is similar
to a Langendorff apparatus function, but fluid flow con-
tinues through an isolated lung (i.e., the right heart con-
tinues to function). The system utilized a cardiovascular
bypass oxygenator and heated water jacketed fluid reser-
voirs to maintain the proper physiologic environment.
The preparations were cradled on custom-sized soft foam
cushions to support the tissue and minimize alteration to
coronary flow. Six to eight liters of modified Krebs-
Henseleit buffer were contained within the system, and
buffer changes of approximately four liters were per-
formed regularly to wash out residual blood and metabo-
lites, and thus to maintain visualization as desired.
Once the specimen was re-warmed to 37 °C, dobuta-
mine was added to the system and the heart was
defibrillated with 34 joules of energy supplied by a
programmer-analyzer unit (#88345 Medtronic PLC,
Minneapolis, MN, USA) via a pair of external patches
(#6721, Medtronic PLC) placed epicardially above and
below the ventricles. These hearts generally began beat-
ing in native sinus rhythm after a single defibrillation. It
should be noted that one human heart developed heart
block at two hours post reanimation, and was then
paced via a temporary pacing lead at a rate of 60 beats
per minute; note that all specimens could be paced if de-
sired. Hemodynamics of the left and right ventricle were
recorded by Utah Medical pressure transducers (Model
DPT-200, lot#1101991, Midvale, UT, USA) via water col-
umns from venogram balloon tipped catheters (Attain
6215, Medtronic PLC).
High-resolution Olympus commercial endoscopes
(Model 1V8200T, Model 1 V8420, Center Valley, PA,
USA) were then placed within the hearts and/or lungs to
visualize the functional anatomy. To our knowledge, we
Fig. 1 (Top right) External view of human heart 277 in systole and attached to the system. (Center) Flow diagram for a functional heart
and lung reanimation consisting of: (1) a respirator connected to the cannulated trachea and thus attached to the lung(s), (2) a pre-load
chamber for the right side of the heart, (3) an aortic after-load chamber which mimics the resistance that the left ventricle works against,
(4) a left pre-load chamber employed when only one lung is present, (5) an oxygenator reservoir for pooling fluid expelled by any
cannulated branch of the pulmonary artery, (6 & 7) fluid pumps to maintain the pre-load pressures, (8) hemostasis valves that allow
access for delivery of cameras, instruments, and assorted devices, (9) valves that may also be used to redirect flow as physiologically
appropriate, while (10) cannulation of the pulmonary vein(s) are shown here for a right lung preparation, but are absent or translated
when either both lungs or the left alone respectively are used
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have been the first group to attempt to visualize the
functional anatomy within pulmonary veins and arteries
within the lung of functioning human heart-lung blocs.
Results and Discussion
Using this novel experimental approach, eighteen swine
and five human heart-lung blocs were successfully reani-
mated. Hemodynamic functioning of these in vitro rea-
nimated specimens was typically augmented by the
delivery of inotropic agents (1.5 mg dobutamine) and/or
by increased dosing with extracellular calcium (0.1 mg/
mL, up to ~35–40 mL calcium chloride). Prior to heart
recovery, the mean heart rate and blood pressure for the
swine were 91 ± 13 beats per minute and 105/56 ± 13/
9 mmHg, respectively. Table 1 provides partial cardiac
medical histories for the organ donors from which the
human hearts were recovered. Table 2 provides the rela-
tive early hemodynamic performance data for these rea-
nimated heart-lung preparations, after hemodynamic
stabilization post defibrillation. These data points are
calculated as 5-min averages at the 1-h time point post
defibrillation.
It should be noted that one of the early reanimated
swine heart-lung specimens (#2) elicited poor
hemodynamic performance from the beginning of reani-
mation. We suspect that injury occurred during isolation
and/or that emboli caused poor coronary perfusion.
Additionally, recorded data from several hearts elicited
negative values for end-diastolic pressures; we suspect
that this is due to a vacuum or syphoning effect, poten-
tially occurring in the perfusion system that was modi-
fied to incorporate the lungs.
Interestingly, compared to our long-term experience
with lone heart reanimations using endoscopes, a large
degree of remaining particulate and blood within the
lung complicated our initial imaging during certain stud-
ies. Therefore, more frequent buffer changes were re-
quired to obtain clear, high-fidelity videoscopic images
of the functional anatomies.
As previously mentioned, a primary benefit of this
model is the maintenance of proper pulmonary ostia
and vessel anatomies. A selected anatomical image
series of a videoscope being retracted from either the
pulmonary arteries or veins is shown in Fig. 2; a cor-
responding video can be accessed via supplemental
materials (Additional file 1) or online at http://www.
vhlab.umn.edu/atlas/left-atrium/pulmonary-vein-distal-
pulmonary-branches/index.shtml.
In addition to the video, Figs. 2 and 3 both display
time series of images captured from these preparations.
Figure 2 shows a videoscope being advanced into the
pulmonary arteries and veins. It can be seen from the
advancement of the videoscope on fluoroscopy (Fig. 2b,
d) that vessel caliber decreases with further advance-
ment. Minimal visual differences were noted between
obtained human and swine images, with respect to the
ability to capture images and the relative image quality.
It was noted that the swine pulmonary veins and left
atria were typically smaller than those observed within
the human specimens. The study of cryoballoon ablation
procedures motivated much of the development of this
model, and a series of cryoballoon procedures have been
performed, as viewed from within the pulmonary vein
and displayed in Fig. 3c. This view was obtained by cre-
ating a small incision distal to the cryoballoon catheter
and advancing the videoscope retrograde. The Add-
itional file 1 of the functioning pulmonary arteries and
veins provides the reader with an appreciation for the
truly dynamic nature of these vessels, which are usually
thought to be relatively passive structures.
The model described here is not without limitations,
as is true with all preclinical in vitro systems. Despite
supersaturating the buffer with oxygen, there remains a
significant difference in the oxygen content of the buffer
compared to blood. For this reason, the function of the
heart slowly declines over time from the initial reanima-
tion due to ongoing global ischemia. Yet reasonable
physiologic function to perform the aforementioned in-
vestigations is generally elicited for up to 4 to 8 h, based
on our previous experience. Interestingly, we also specu-
lated that the addition of the lungs may possibly extend
the functionality of isolated reanimated preparations, a
Table 1 Summary of donor information and hemodynamic status prior to organ recovery
Human Specimens
Specimen Gender Age (yrs) Weight (kg) Cause of Death HR (bpm) BP (mmHg) CVP (mmHg)
HH 277 M 60 113.4 Head trauma 71 105/61 15
HH 284 F 78 54.4 CVA 103 118/70 11
HH 291 F 58 114.7 CVA 92 100/50 12
HH 295 M 34 68.0 Cardiac arrest 92 130/75 -
HH 308 F 36 53.0 CVA, transplant complications 87 97/71 10
Average 53.2 80.7 89.0 110/65 12
Standard Dev. 18.4 31 11.6 14/10 2.2
BP blood pressure, HR heart rate, CVA cerebrovascular accident, CVP central venous pressure
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theory that we tend to believe at this point but need
more data to substantiate. Most recently, we are employ-
ing a full anesthesia suite ventilator to more closely con-
trol the ventilation parameters (e.g., provide positive
end-expiratory pressure). In such experimentation, one
also needs to consider that although it is known that hy-
pothermal transport of organs is protective, global ische-
mic injury still occurs to some degree. Further, our
current system is designed to replicate physiologic pre-
and after-loads, but there potentially are important
physiological effects that are not completely replicated,
such as vessel compliance. Likewise, in our studies the
heart-lung blocs are cradled on soft foam sponges which
may somewhat focally alter perfusion compared to the
natural state; also the pericardium has been removed.
Finally, due to the nature of acquiring non-viable
donor human heart-lung specimens, there are numer-
ous differences between inherent status of the hearts
that cannot be controlled. Such differences in status
include, but are not limited to: methods of cardiac ar-
rest, transport times before arriving in the laboratory,
clinically required inotropic support, potential air or
other emboli in the coronary vasculature (potentially
generated during explantation), and/or prior patholo-
gies. Despite being unable to control for these param-
eters, the described system produced comparable
pressures to other isolated human heart alone prepa-
rations [2, 16]. As reviewed in Table 2, despite these
Table 2 Hemodynamic performance of reanimated heart/lung bloc specimens over 5-min period after hemodynamic stabilization
1-h post defibrillation
Swine Specimens
Specimen HR (bpm) LVSP (mm Hg) LVEDP (mm Hg) +dLVP/dt (mm Hg/s) -dLVP/dt (mm Hg/s) Tau Lung
1 95.8 91.2 12.4 982.8 −903.0 31.2 Right
2 91.0 25.0 −2.0 430.8 −343.8 36.2 Right
3 100.0 77.0 −4.0 961.0 −462.0 30.0 Right
4 81.7 73.5 2.3 772.3 −354.5 37.7 Right
5 91.8 85.7 1.3 927.0 −509.8 33.2 Right
6 99.5 62.8 11.3 574.0 −435.0 30.2 Right
7 55.8 82.0 5.7 600.2 −358.2 63.0 Right
8 90.3 79.3 −4.3 842.5 −618.0 33.5 Left
9 92.7 75.7 12.0 623.3 −771.7 32.5 Left
10 102.5 67.5 1.2 637.8 −513.2 29.7 Right
11 76.7 101.7 10.7 786.5 −501.5 39.7 Right
12 123.3 76.3 1.3 729.0 −624.5 26.0 Right
13 124.8 58.7 2.7 762.5 −532.7 24.0 Right
14 84.5 87.2 0.7 888.8 −646.0 54.0 Right
15 114.0 91.7 −2.7 922.3 −808.0 27.5 Right
16 105.0 70.8 0.0 607.7 −446.3 28.8 Right
17 101.3 56.5 3.8 529.8 −317.7 29.8 Right
18 91.2 75.7 7.0 618.3 −810.2 33.0 Right
Average 95.7 74.3 3.3 733.2 −553.1 34.4
Standard Dev. 16.3 17 5.4 163.6 177.6 9.7
Human Specimens
HH 277 85.8 65.7 −7.3 624.5 −475.5 37.2 Right
HH 284 81.2 79.5 1.7 848.2 −377.7 37.5 Right
HH 291 70.3 53.3 8.0 341.3 −273.7 45.3 Both
HH 295 81.3 72.5 4.2 415.7 −343.0 37.7 Right
HH 308 57.2 73.0 0.0 963.0 −469.8 56.2 Right
Average 75.2 68.8 1.3 638.5 −387.9 42.8
Standard Dev. 11.6 9.9 5.7 268.1 86 8.2
HR heart rate, LVSP left ventricular systolic pressure, LVEDP left ventricular end-diastolic pressure, +dLVP/dt maximal positive derivative of left ventricular pressure
with respect to time, −dLVP/dt maximal negative derivative of left ventricular pressure with respect to time
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potential variances, the hemodynamic data are fairly
comparable from specimen to specimen. It should be
specifically noted that we are extremely grateful and
privileged to obtain these donated human heart-lung
preparations as gifts for research.
Conclusions
The experimental techniques described here can be re-
producibly employed to study heart-lung bloc prepara-
tions with viable cardiac and pulmonary performance.
However, it was often observed that cardiac performance
Fig. 2 Image series obtained from reanimated human heart-lung bloc 284 (a, b) and 277 (c, d). The image series shows the path through
the distal pulmonary arteries (a, b) and veins (c, d). The corresponding fluoroscopic images (b, d) in each case show the relative locations
of the videoscopes (a, c). A video of the journey through the vasculature can be viewed as well (see Additional file 1)
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Fig. 3 (See legend on next page.)
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(i.e., blood pressure) was somewhat reduced in these
preparations compared to their in situ, native behaviors
(Tables 1 and 2). This is likely due in part to the hypoxic
environment induced by replacing blood with a clear
perfusate, but it is also related to the lack of autonomic
system innervation. Nevertheless, this novel approach
has uniquely enabled visualization of pulmonic anat-
omies. To the authors’ knowledge, this report has pro-
vided first time dynamic videoscopic images of the
pulmonary vasculature during self-sustained cardiac
function in both reanimated human and swine heart-
lung blocs. This unique translational in vitro approach
also provides a unique preclinical means to study novel
medical therapeutics, i.e., from large mammals, includ-
ing human and heart-lung specimens.
In a similar embodiment (i.e., without the lungs), this
reanimated heart model has been utilized in numerous
cardiac studies. In the electrophysiologic area, these
studies have included the use of endocardial noncontact
mapping, pacemakers, defibrillators, leads, and catheters
[17]. The Visible Heart® model has also been employed
to study the dynamic nature of valves and transcatheter
valve deployment [18]. Importantly these methodological
approaches also allow for the simultaneous use of echo-
cardiography and fluoroscopy to guide procedures, such
as for comparative imaging [19]. Most recently, this ap-
proach has proven to be quite valuable for the study of
novel cardiac treatments, such as leadless pacing devices
[20]. Yet, the novel addition of a lung(s) to this paradigm
allows for any of the prior studies to be conducted, but
may in turn reduce the number of hemostasis valve ac-
cess points that were previously available. Nevertheless,
our described reanimation of heart-lung blocs could be
adapted to validate swine pulmonic disease models, as
swine specimens are more readily available for routine
experimentation. It should also be noted that human
heart-lung bloc specimens often have associated pul-
monary dysfunction. Although our current research has
focused on native swine and human specimens, one can
imagine the use of this experimental approach for spe-
cific disease model testing of either devices or pharma-
cologic treatments, for instance device or pharmacologic
efficacy experiments using COPD or emphysema swine
models. In other words, the addition of the lungs to iso-
lated, reanimated heart preparations opens up a wide
variety of preclinical/translational cardio-pulmonary
research.
Our continued use and enhancement of Visible Heart®
methodologies have also facilitated the creation of an
open-access educational website, The Atlas of Human
Cardiac Anatomy (www.vhlab.umn.edu/atlas) [21]. The
anatomical images and videos on this website are free to
download and use for presentations and teaching, how-
ever we request that proper citations be used. The novel
images and/or comparative imaging of functional cardiac
anatomies are of high value in teaching the nuances of
cardiac anatomy, especially those of active, complex
structures such as valve anatomies. This website also
provides instructional tutorials on cardiac anatomy and
physiology, as well as full cadaveric thoracic cavity dis-
sections. Finally, a cardiac device tutorial is also avail-
able, which has been well noted as being beneficial in
explaining therapies to patients.
To conclude, this extension of Visible Heart® method-
ologies to successfully reanimate human and swine
heart-lung blocs has enabled novel, functional heart-lung
anatomical visualization. Further, unique abilities to
image device-tissue interactions using this approach are
unparalleled. Therefore, we consider that these images
are of high value to medical device designers, educators,
and clinicians for both training and educational pur-
poses. The lab will continue to reanimate hearts and
heart-lung blocs using these methodologies and thereby
enable novel studies of dynamic anatomies, insights into
the device-tissue interface, and continued generation of
new materials for the free-access Atlas of Human Car-
diac Anatomy website.
Additional file
Additional file 1: Reanimated Heart-Lung Bloc Imaging. Video obtained
from reanimated human heart-lung blocs: 1) human heart 277 (pulmonary
veins); 2) human heart 295 (pulmonary arteries); 3) human heart 284 (mitral
valve); and 4) human heart 291 (tricuspid valve). (MP4 9135 kb)
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